In order to determine whether type(s) of immunologic reaction (mainly Arhtus reaction) other than the immediate type reaction are related to the development of bronchial asthma the following experiment was done. Eighty patients with bronchial asthma received bronchial provocation and skin tests. These were compared to time-related changes in serum CH50, counts of blood and nasal eosinophils, types of asthma, and effectiveness of immunotherapy. The antigens used were house dust, polyvalent vaccine and mixed fungal antigens. It was found that: 1. No apparent correlation was observed between the type of bronchial response and the type of skin reaction. However, most of the patients with type III or III+IV skin reaction showed a late asthmatic response (LAR). 2. Infectionus type asthmatics tended to show a LAR more more than atopic type asthmatics. 3. Serum CH50 in the patients who received inhalation tests remained within the normal range, except for one patient whose CH50 level decreased 6 hours after the inhalation. This patient had a type I+III skin reaction with a LAR. 4. By double immunodiffusion test, precipitating antibody against house dust was found in two cases. One showed a LAR, the other a dual type reaction. By single radial immunodiffusion test, the precipitating antibody against Staph. Aureus was found in three cases. One of these showed a LAR, another a dual type bronchial response and the third, no bronchial response. 5. Counts of blood eosinophils decreased one hour following the inhalation test, in patients who showed an immediate or dual bronchial response. Thereafer eosinophil counts gradually increased, reaching a maximum at 12-24 hours. Nasal eosinophils increased reaching a maximum 1-3 hours after the inhalation test. In cases with a late bronchial response, however, no significant change in eosinophil counts was observed. 6. The relationship between type of bronchial response and effectiveness of immunotherapy was as follows: In patients showing an immediate bronchial response, immunotherapy was 100% effective. In patients with a dual bronchial response, it was 75.0% effective and in LAR patients, it was 72.7% effective. The effectiveness of immunotherapy in these groups with a possitive bronchial response was significantly higher than the effectiveness in the negative bronchial response group. From these results, it is suggested that most patients developed bronchial asthma by the mechanism of the immediate type reaction. However, it should be considered that Arthus and/or delayed type reactions are also involved in the induction of bronchial asthma.
View full abstract